Navigating UnitedHealthcare Ultomiris Prior Authorization

Successfully managing UnitedHealthcare Ultomiris prior authorization is critical for patient access to this high-cost specialty medication. Klivira provides the automation and connectivity to navigate UHC's specific requirements.

Ultomiris (ravulizumab) is a C5 complement inhibitor indicated for rare conditions such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). As a high-cost specialty drug, it is a frequent target for prior authorization across UnitedHealthcare's commercial, Medicare Advantage, and Medicaid managed care plans. Efficient PA management is essential to prevent treatment delays and revenue cycle disruptions.

UnitedHealthcare's Channels for Ultomiris Prior Authorization Submission

UnitedHealthcare employs distinct submission channels for specialty drugs like Ultomiris, depending on whether the drug falls under the medical or pharmacy benefit. Understanding these pathways is crucial for timely approval and avoiding administrative denials.

Key Submission Channels for Ultomiris PA:

**OptumRx:** As UnitedHealth Group's PBM, OptumRx manages pharmacy benefit prior authorizations for specialty drugs, including those dispensed through mail-order or Optum Specialty Pharmacy.
**UnitedHealthcare Provider Portal (uhcprovider.com):** Medical benefit Ultomiris prior authorizations, particularly for infused or injected forms administered in a clinical setting, are primarily submitted via the Prior Authorization and Notification tool on UHCprovider.com.
**X12 278 Transactions:** For medical benefit Ultomiris prior authorizations, X12 278 transactions are accepted via clearinghouses, offering an electronic data interchange (EDI) option for eligible procedures.
**ePA Partners (CoverMyMeds, Surescripts):** For retail pharmacy benefit Ultomiris, prescribers can utilize ePA platforms like CoverMyMeds and Surescripts, which integrate with OptumRx workflows.

Navigating UnitedHealthcare's Medical Policy and Criteria for Ultomiris

UnitedHealthcare publishes comprehensive medical necessity criteria and coverage rules in its public Medical Policy Library. For Ultomiris, specific drug policies will outline clinical indications, dosing, and step therapy requirements. Revenue cycle teams must verify the current policy number and effective date to ensure accurate submissions.

Common Denial Reasons and Appeal Pathways for Ultomiris with UnitedHealthcare

Denials for Ultomiris prior authorizations from UnitedHealthcare often stem from insufficient clinical documentation or failure to meet specific medical necessity criteria. Other common reasons include site-of-service mismatches for infusions, or non-formulary status if submitted incorrectly. UnitedHealthcare provides clear appeal pathways, including peer-to-peer reviews for clinical denials, as documented in their provider administrative guides.

CMS-0057-F Impact on Ultomiris PA for UnitedHealthcare Medicare Advantage and Medicaid Plans

For Ultomiris prior authorizations submitted for UnitedHealthcare's Medicare Advantage, Community Plan (Medicaid managed care), and CHIP managed care lines, CMS-0057-F mandates specific decision timeframes: 72 hours for standard PA and 24 hours for expedited PA. Klivira's platform is designed to align with these regulatory requirements, facilitating efficient processing and adherence to phased electronic PA API conformance by 2027. It's important to note that UnitedHealthcare's commercial plans are not directly impacted by this CMS rule.

Klivira's Solution for UnitedHealthcare Ultomiris Prior Authorization

Klivira automates the complex process of obtaining UnitedHealthcare Ultomiris prior authorization by integrating directly with your EMR and UHC's diverse submission channels. Our platform minimizes manual effort, accelerates turnaround times, and provides real-time status updates, significantly reducing administrative burden and improving patient access to critical treatments.

Frequently asked questions

How do I submit Ultomiris prior authorizations to UnitedHealthcare?

Ultomiris prior authorizations for UnitedHealthcare are submitted via OptumRx for pharmacy benefits or through the UnitedHealthcare Provider Portal (uhcprovider.com) or X12 278 transactions for medical benefits. Retail pharmacy ePA can also be submitted via CoverMyMeds or Surescripts.

Which UnitedHealthcare entity handles Ultomiris for pharmacy vs. medical benefits?

OptumRx, UnitedHealth Group's PBM, handles Ultomiris when covered under the pharmacy benefit. For Ultomiris covered under the medical benefit (e.g., infused in a clinic), the prior authorization is processed through UnitedHealthcare's medical claims system via the UHCprovider.com portal or X12 278.

What are common reasons for UnitedHealthcare Ultomiris PA denials?

Common denial reasons for Ultomiris PA with UnitedHealthcare include insufficient clinical documentation to establish medical necessity, failure to meet specific policy criteria, or site-of-service mismatches for infusions. Benefit exclusions or non-formulary status can also lead to denials.

Does CMS-0057-F apply to all UnitedHealthcare Ultomiris prior authorizations?

No, CMS-0057-F specifically applies to Ultomiris prior authorizations for UnitedHealthcare's Medicare Advantage, Community Plan (Medicaid managed care), and CHIP managed care lines. It does not directly impact commercial plans.

How can I access UnitedHealthcare's medical policies for Ultomiris?

UnitedHealthcare's medical policies, including those relevant to Ultomiris, are publicly available in their Medical Policy Library. It is essential to review the specific policy number and effective date for the most current coverage criteria.